Arno Therapeutics, Inc Earnings Per Share (Diluted)
Arno Therapeutics, Inc reported Earnings Per Share (Diluted) of -$0.56 per share for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-30.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2016-03-30
- Arno Therapeutics, Inc earnings per share, diluted for the quarter ending 2015-12-31 was -$0.20, a 206.50% decline year-over-year.
- Arno Therapeutics, Inc earnings per share, diluted for the quarter ending 2015-09-30 was -$0.03, a 400.00% decline year-over-year.
- Arno Therapeutics, Inc earnings per share, diluted for the quarter ending 2015-06-30 was -$0.17, a 221.43% decline year-over-year.
- Arno Therapeutics, Inc earnings per share, diluted for the quarter ending 2015-03-31 was -$0.17.
- Arno Therapeutics, Inc earnings per share, diluted for fiscal 2015 was -$0.56, a 280.65% decline from fiscal 2014.
- Arno Therapeutics, Inc earnings per share, diluted for fiscal 2014 was $0.31.
- Arno Therapeutics, Inc earnings per share, diluted for fiscal 2013 was -$5.28.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2015-12-31 | -$0.20 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$0.23 derived: net income ÷ weighted average shares · filed 2016-11-14 | -$0.40 derived: net income ÷ weighted average shares · filed 2016-11-14 | -$0.56 10-K · filed 2016-03-30 |
| 2015-09-30 | -$0.03 10-Q · filed 2015-11-16 | -$0.20 derived: net income ÷ weighted average shares · filed 2016-11-14 | -$0.37 10-Q · filed 2015-11-16 | -$0.14 derived: net income ÷ weighted average shares · filed 2016-11-14 |
| 2015-06-30 | -$0.17 10-Q · filed 2015-08-14 | -$0.33 10-Q · filed 2015-08-14 | -$0.10 derived: net income ÷ weighted average shares · filed 2016-08-22 | -$0.09 derived: net income ÷ weighted average shares · filed 2016-08-22 |
| 2015-03-31 | -$0.17 derived: net income ÷ weighted average shares · filed 2016-05-16 | $0.05 derived: net income ÷ weighted average shares · filed 2016-05-16 | $0.06 derived: net income ÷ weighted average shares · filed 2016-05-16 | $0.20 derived: net income ÷ weighted average shares · filed 2016-05-16 |
| 2014-12-31 | $0.18 derived: net income ÷ weighted average shares · filed 2016-03-30 | $0.19 derived: net income ÷ weighted average shares · filed 2016-03-30 | $0.33 derived: net income ÷ weighted average shares · filed 2016-03-30 | $0.31 10-K · filed 2016-03-30 |
| 2014-09-30 | $0.01 10-Q · filed 2015-11-16 | $0.15 derived: net income ÷ weighted average shares · filed 2015-11-16 | $0.13 10-Q · filed 2015-11-16 | -$0.96 derived: net income ÷ weighted average shares · filed 2015-11-16 |
| 2014-06-30 | $0.14 10-Q · filed 2015-08-14 | $0.12 10-Q · filed 2015-08-14 | -$1.02 derived: net income ÷ weighted average shares · filed 2015-08-14 | -$1.48 derived: net income ÷ weighted average shares · filed 2015-08-14 |
| 2014-03-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2015-05-15 | -$1.34 derived: net income ÷ weighted average shares · filed 2015-05-15 | -$2.04 derived: net income ÷ weighted average shares · filed 2015-05-15 | -$3.42 derived: net income ÷ weighted average shares · filed 2015-05-15 |
| 2013-12-31 | -$1.51 derived: net income ÷ weighted average shares · filed 2015-03-31 | -$2.65 derived: net income ÷ weighted average shares · filed 2015-03-31 | -$4.55 derived: net income ÷ weighted average shares · filed 2015-03-31 | -$5.28 10-K · filed 2015-03-31 |
| 2013-09-30 | -$0.75 10-Q · filed 2014-11-14 | -$3.07 derived: net income ÷ weighted average shares · filed 2014-11-14 | -$3.34 10-Q · filed 2014-11-14 | |
| 2013-06-30 | -$2.35 10-Q · filed 2014-08-14 | -$2.61 10-Q · filed 2014-08-14 |